Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Leukemia 27Lymphoma 25Lymphoma, Non-Hodgkin 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Multiple Myeloma 21Leukemia, Myeloid, Acute 21Hodgkin Disease 16Leukemia, Lymphocytic, Chronic, B-Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Hematologic Neoplasms 10Neuroblastoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Graft vs Host Disease 6Neoplasms, Plasma Cell 5Leukemia, Myelomonocytic, Juvenile 5Breast Neoplasms 5Hemoglobinuria, Paroxysmal 4Rhabdoid Tumor 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Myeloid, Accelerated Phase 3Ganglioneuroblastoma 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Anemia, Aplastic 3Wilms Tumor 2Recurrence 2

Interventions

3-Iodobenzylguanidine 5Doxorubicin 3cabozantinib 2Temozolomide 2Radiotherapy 2Phenoxybenzamine 2Ifosfamide 2Filgrastim 2Everolimus 2Doxazosin 2Dexmedetomidine 2vatalanib 1temsirolimus 1pegfilgrastim 1lenvatinib 1fostamatinib 1atezolizumab 1anlotinib 1Vinorelbine 1Tamoxifen 1Sunitinib 1Stem Cell Transplantation 1Sirolimus 1Saline Solution 1Quality of Life 1Patient Reported Outcome Measures 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pheochromocytoma × Stem Cell Transplantation × Clear all
NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
15 enrolled
CNSEndocrine

Neuroblastoma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡